Latest Regenerative June 29, 2025 News

Subscribe

Xtant Medical Releases Growth Factor Product to Improve Orthopedic/Spine Surgery Outcomes

OsteoFactor Proâ„¢ targets improved orthopedic healing through enhanced bone regeneration and versatile scaffold compatibility.

NextCell Pharma Completes Patient Dosing in Pediatric Diabetes Stem Cell Study

The company has concluded dosing in its largest pediatric diabetes trial, evaluating ProTrans therapy's safety and insulin-preserving potential

Vertex Reports Promising Results from Stem Cell Trial for Type 1 Diabetes

Vertex recently presented encouraging Phase 1/2 results for zimislecel, a stem cell-derived therapy showing sustained insulin production in type 1 diabetes patients.

STEMCELL Technologies Acquires Cellular Highways to Enhance Cell Sorting Technology

The acquisition is expected to help expand its cell therapy capabilities, gaining advanced microfluidic cell sorting tech for enhanced research

CellProthera Selects CELLforCURE to Manufacture Stem Cells for Phase 3 Heart Failure Study

CellProthera is gearing up for Phase 3 cardiac regeneration trials, moving one step closer to producing clinical batches of ProtheraCytes®, it's stem cell candidate
x
Subscribe
Subscribe

Stay updated on Regenerative Medicine

Subscribe